Immutep

-$0.06 (-1.67%) Today
+$0.00 (+0.03%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.

About IMMP

Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma.

CEO
Marc Voigt
Employees
—
Headquarters
Sydney, New South Wales (NSW)
Founded
1987

IMMP Key Statistics

Market Cap
351.91M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
433.41K
High Today
$3.62
Low Today
$3.52
Open Price
$3.61
Volume
302.19K
52 Week High
$7.95
52 Week Low
$1.22

IMMP Earnings

Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Jul 30, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure